$452m Adeza buy adds early birth risk test to Cytyc's ob/gyn offering
This article was originally published in Clinica
Executive Summary
A noninvasive test that helps identify pregnant women at risk of pre-term delivery is the key component in the latest acquisition deal signed by Cytyc.